Earnings

BlossomHill Therapeutics Q2 EPS $(8.75)

Sep 18, 2026 · 07:08 AM ET· updated 1h ago

BlossomHill Therapeutics (NASDAQ:BLSM) reported quarterly losses of $(8.75) per share. This is a 58.8 percent decrease over losses of $(5.51) per share from the same period last year.

Why It Matters

BlossomHill lost more money per share this quarter than last year. When a company's losses grow bigger, it means they are spending cash faster than before.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BLSM26.79

-0.03 (-0.11%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.